Close Menu

More Losses

Layoffs are hitting Sanofi-Aventis and possibly Astra-Zeneca and Eli Lilly, says Derek Lowe at In the Pipeline. He says that Astra-Zeneca's cuts may be "follow-through from their earlier nonspecific announcements - it looks as if they're finally going to start getting down to some details" and that at Lilly, some chemistry positions may be lost.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The New York Times reports that the US Food and Drug Administration has authorized Johnson & Johnson's SARS-CoV-2 vaccine.

Nature News writes that additional details about the UK plan for an agency to support high-risk, high-reward science are needed.

The Wall Street Journal writes new studies are giving glimpses into the origins of SARS-CoV-2.

In PLOS this week: analysis of Plasmodium population structure, qPCR assay to diagnose scabies, and more.